TRANSCEND FL: Phase II Study Results of Lisocabtagene Maraleucel (Liso-Cel) in Patients With R/R Follicular Lymphoma (FL)
Loretta J. Nastoupil,Saurabh Dahiya,M. Lia Palomba,Alejandro Martin Garcia-Sancho,Juan Luis Reguera Ortega,John Kuruvilla,Ulrich Jager,Guillaume Cartron,Koji Izutsu Izutsu,Martin Dreyling,Brad Kahl,Herve Ghesquieres,Kirit Ardeshna,Hideki Goto,Anna Maria Barbui,Jeremy S. Abramson,Peter Borchmann,Isabelle Fleury,Stephan Mielke,Thalia Farazi,Omotayo Fasan,James Lymp, Min Vedal,Rina Nishii,Ariel Avilion, Jessica Papuga, Frank Morschhauser CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
关键词
IBCL, indolent NHL, relapsed or refractory, follicular lymphoma, liso-cel, third line or later, Phase II
AI 理解论文
溯源树
样例
